Sacubitril/Allisartan Isoproxil

沙库巴曲/阿利沙坦酯

Report date: 2026/02/25 20:02:36
NME

Base Information

Drug NameSacubitril/Allisartan Isoproxil
Drug Alias NameAllisartan Isoproxil/Sacubitril沙库必曲/阿利沙坦酯阿利沙坦酯+沙库巴曲沙库巴曲阿利沙坦钙信超妥 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeprilysin inhibitorsAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1Neprilysin
Therapy Area/IndicationsEssential HypertensionHypertensionHeart Failure
Global Approved IndicationsEssential Hypertension
Approved Indications in ChinaEssential Hypertension
Original Approved Country/TerritoryMainland China
Original Approved Date2025/05/20
Country/TerritoryMainland China
CombinationsYes Allisartan IsoproxilSacubitril
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsEssential HypertensionHeart Failure
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A